Full-Time

Quality Supervisor

Posted on 5/9/2026

Integer Holdings Corporation

Integer Holdings Corporation

1,001-5,000 employees

Medical device CDMO for cardiac devices

No salary listed

Roanoke, VA, USA

In Person

Category
Biology & Biotech (1)
Required Skills
ISO 9001
FDA Regulations
Requirements
  • Bachelor’s degree in an engineering or related technical field
  • Minimum of 3 years of experience
  • Knowledge and experience with the specific product line or function you will support, such as manufacturing quality, supplier quality or quality engineering
  • Specialized knowledge of quality system regulations and standards important to the role (e.g., EU Medical Device Regulation, ISO 13485, ISO 9001, Good Manufacturing Practices 21 CFR 820 and Good Documentation Practices) and auditing experience
  • Demonstrated leadership ability to lead, create and share a coordinated vision, and align a team to resolve what needs to be done
  • Clear preference for working in a team environment and prioritizing the team over self
  • Ability to work in a fast-paced, complex manufacturing environment while maintaining calm demeanor
  • Ability to work independently and collaboratively with cross-functional teams
  • Solid technical aptitude and ability to contribute to a team or produce results as an individual
  • Effective written and oral communication and interpersonal skills
  • Bias for action, decision making and problem-solving skills
  • Positive, can-do attitude with belief that failure is not an option
Responsibilities
  • Coordinate team deliverables and provide daily direction to a team of quality professionals to ensure quality requirements, performance goals and improvement objectives for a manufacturing site are achieved, with a focus on performance management and development of direct reports in support of the Quality Management System
  • Adhere to company policies and procedures and all safety and quality requirements including Quality Management Systems, Environmental Management Systems, FDA regulations and other regulatory requirements as required
  • Lead efforts to identify potential gaps in existing processes and drive process improvements required to enable department to execute at a more accurate and efficient level
  • Supervise, coach, and direct a team of quality professionals in support of one or more product lines or process areas within a manufacturing site
  • Promote teamwork, cross-functional consensus building, and accountability within the team and interactions with others inside and outside Integer
  • Promote a diverse and inclusive work environment where team feels supported and openly communicates opportunities and issues
  • Provide first level support for resolving day-to-day issues raised by team members and seek cross-functional support for resolution as needed
  • Review and approve engineering change requests, nonconformance reports and engineering reports
  • Establish daily/weekly/monthly objectives for team members and support Individual Development Plans as roadmap for professional and personal skills development
  • Drive an appropriate level of process control using a risk-based approach
  • Ensure compliance to the established Quality Management System
  • Engrain a culture of quality within the team
  • Embed Quality – “I own Quality.” support corrective and preventive actions investigations and implementations, and contribute to attainment of quality KPI’s
  • Apply standard data analysis practices and observe products and processes to establish root cause for product and process failures or to support improvements
  • Support internal and external quality audit activities, as applicable
  • Investigate and disposition non-conforming materials and assure adequacy of corrective actions to prevent re-occurrence
  • Lead and manage complaint investigations
  • Participate in plant Corrective and Preventive Actions activities, including data analysis and root cause analysis
  • Apply data analysis practices to establish root cause for product and process failures to drive improvements
  • Embrace Manufacturing Excellence culture based on Integer Production System and five focus areas: Strategy Alignment, Leadership of Sustained Change, Standardisation, Associate Engagement, Systems & Process Optimization
  • Support Strategy Alignment through Site Hoshin Plans, quality planning meetings, and updates to QA RA metrics
  • Lead sustained change by initiating and completing customer change notifications and supporting continuous improvement activities
  • Standardisation through workplace organization and visual controls, Manufacturing Standard Work, robust training and certification programs, and alignment with enterprise Quality Management System
  • Associate Engagement through standardized problem solving methodologies, safety programs, and improvement idea systems
  • Systems & Process Optimization through built-in quality, optimized scheduling and material system designs, work cell design, and total production maintenance
  • Safety is the highest priority and you will be an active supporter of Environmental, Health & Safety programs
  • Define Goals and Objectives with key projects and milestones
  • Quality metrics including Customer Direct Complaint Rate, NCR rate, Complaint Cycle Time, CAPA Cycle Time, and Supplier Performance
  • Delivery metrics including achievement of scheduled tasks and milestones for assigned projects
  • Cost metrics including continuous improvement and ideation and implementation
  • People metrics including associate engagement and timely handling of associate relations issues
  • Minimum education: Bachelor’s degree in an engineering or related technical field
  • Minimum experience: 3 years of experience
  • Specialized knowledge: knowledge and experience with product line or function (manufacturing quality, supplier quality or quality engineering) and quality system regulations/standards and auditing experience
  • Specialized skills: leadership, teamwork, communication, bias for action, positive attitude
Desired Qualifications
  • None
Integer Holdings Corporation

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Simplify Jobs

Simplify's Take

What believers are saying

  • Board initiated strategic review on April 30, 2026, exploring sale options.
  • Irenic Capital acquired $99M stake in Q4 2025 as top holding.
  • $200M share repurchase authorization signals management confidence in valuation.

What critics are saying

  • Class action lawsuits by Pomerantz and Bleichmar drain cash via settlements by Q4 2026.
  • Three new products cause 3-4% headwind, slashing H2 2026 margins.
  • Irenic activism forces sale at depressed valuation below $93 target in 12 months.

What makes Integer Holdings Corporation unique

  • Integer specializes in contract manufacturing for Cardio & Vascular medical devices.
  • Organic revenue grew 1.3% in Q1 2026 despite flat overall sales.
  • Robust pipeline targets above-market growth by 200 basis points in 2027.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Integer Holdings Corporation who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 24th, 2026
Integer VP sells $70K in shares as stock drops 28% in a year

Integer Holdings Corporation shares fell 28% following an insider sale disclosure. Tom Thomas, the company's vice president and corporate controller, sold 825 shares of common stock in an open-market transaction on 13 March 2026, according to an SEC Form 4 filing. The transaction was valued at $70,000 at a reported price of $85 per share. The sale represented 15.85% of Thomas's direct holdings at the time. Following the transaction, Thomas holds 4,380 shares worth approximately $364,000. This marks Thomas's third open-market sale since 2018, following previous sales of 884 shares in November and 1,500 shares in April. Integer Holdings manufactures medical devices and components, generating $1.85 billion in trailing twelve-month revenue.

Yahoo Finance
Feb 26th, 2026
Integer Holdings Q4 earnings beat forecasts on strong Cardio & Vascular demand

Integer Holdings, a medical device manufacturer, reported fourth quarter revenue of $472.1 million and adjusted earnings per share of $1.76, both exceeding analyst expectations. The company posted 5% year-on-year revenue growth, driven by strong performance in its Cardio & Vascular segment. CEO Peyman Khales attributed $30 million in operational improvements to higher sales volume, manufacturing efficiencies and expense management. The company guided adjusted earnings per share of $6.54 for 2026, beating analyst estimates by 3.8%. During the earnings call, analysts questioned the narrowing of organic sales guidance, first quarter margin compression and the company's path to above-market growth in 2027. Management emphasised collaborative customer planning and reaffirmed its current strategy despite activist investor involvement.

Intellectia.AI
Feb 23rd, 2026
Irenic Capital takes $99M stake in Integer Holdings as medical device firm posts 8% sales growth

Irenic Capital Management has acquired a $99.11 million stake in Integer Holdings, purchasing 1,263,663 shares in Q4 2026. The position represents 13.7% of Irenic's assets under management, making it the fund's largest disclosed equity holding. Integer Holdings, a medical device company, achieved 8% sales growth in 2025, reaching $1.85 billion in revenue, with adjusted earnings per share rising 21% to $6.40. The company reported fourth-quarter sales of $472 million and net income of $62 million, up 22% year-over-year. Management projects 2026 adjusted earnings per share between $6.29 and $6.78, with plans to achieve organic growth exceeding market rates by 200 basis points in 2027. Benchmark analyst Robert Wasserman upgraded the stock from hold to buy with a $95 price target.

Yahoo Finance
Feb 23rd, 2026
Integer posts 21% adjusted EPS growth but warns of H1 2026 headwinds from slower product adoption

Integer Holdings reported strong 2025 results with sales up 8% and adjusted earnings per share rising 21% to $6.40, alongside margin expansion and $105 million in free cash flow. The company returned capital through a $50 million share repurchase and announced an additional $50 million accelerated share repurchase programme. However, management warned that three newer products representing approximately 6% of 2025 sales are experiencing slower-than-expected adoption, creating a 3%–4% headwind for 2026. The company expects flat-to-slightly-down sales and a 200–250 basis point hit to first-quarter operating margin, with recovery and margin expansion anticipated in the second half. Integer maintained its 2026 midpoint guidance, with year-end net debt expected at $1.17–1.19 billion and net leverage remaining at 3.0 times adjusted EBITDA.

Yahoo Finance
Feb 19th, 2026
Integer faces 2026 headwinds from delayed product launches despite $200M buyback and robust pipeline

Integer Holdings, a medical device contract manufacturing organisation, reported fourth-quarter sales of $472 million, up 5% year-over-year, with adjusted earnings per share at the high end of its October guidance range. For the full year 2025, sales increased 8% on a reported basis and over 6% organically, whilst adjusted operating income rose 13%. The company issued 2026 guidance expecting reported sales to be down 1% to up 1%, with a 3% to 4% headwind from three new products facing lower-than-expected market adoption. However, Integer's underlying business is expected to grow 4% to 6%, in line with the market. Integer repurchased $50 million of shares in Q4 and announced plans for an additional $50 million accelerated share repurchase programme under its $200 million authorisation.